Cargando…
Fixed‐Dose Combination Medication Use Among US Adults With Hypertension: A Missed Opportunity
Autores principales: | Mobley, Claire M., Bryan, Alexis S., Moran, Andrew E., Derington, Catherine G., Zhang, Yiyi, Bellows, Brandon K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111489/ https://www.ncbi.nlm.nih.gov/pubmed/36734429 http://dx.doi.org/10.1161/JAHA.122.027486 |
Ejemplares similares
-
Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020
por: Derington, Catherine G., et al.
Publicado: (2023) -
Cost-Effectiveness of Masked Hypertension Screening and Treatment in US Adults With Suspected Masked Hypertension: A Simulation Study
por: Green, Matthew B, et al.
Publicado: (2022) -
Rational approaches to the treatment of hypertension: drug therapy—monotherapy, combination, or fixed-dose combination?
por: Canbakan, Başol
Publicado: (2013) -
Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products
por: Holló, Gábor, et al.
Publicado: (2014) -
Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
por: Maillard, Marc P, et al.
Publicado: (2007)